ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Obesity"

  • 2017 American Transplant Congress

    Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.

    A. Keidar,1 R. Yemini,1 I. Carmeli,1 E. Nesher,2 J. Vinkler,2 E. Mor,2 M. Bendavid.1

    1Surgery, Beilinson Hospital, Tel Aviv, Israel; 2Transplantation, Beilinson Hospital, Tel Aviv, Israel

    Objectives: To report the safety and feasibility of maintaining immunosuppression and graft safety after bariatric surgery among solid organ transplanted patients.Summary Background Data: Transplanted patients…
  • 2017 American Transplant Congress

    Bariatric Operations at a Service of the Transplant Surgery.

    A. Keidar,1 R. Yemini,1 M. Ben David,1 E. Nesher,2 J. Vinkler,3 M. Broun,2 E. Mor.2

    1Surgery, Beilinson Hospital, Tel Aviv, Israel; 2Transplantation, Beilinson Hospital, Tel Aviv, Israel; 3Nephrology, Beilinson Hospital, Tel Aviv, Israel

    IntroductionInvolvement of bariatric operations in the peri-transplant setting could be at different stages – prospective living organ donor (group 1), prospective organ recipient (2), patients…
  • 2017 American Transplant Congress

    Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?

    E. van Hardeveld,1 T. Furlong,2 A. Robertson,2 N. Suh,2 S. Thwaites,2 R. Millar,2 R. Masterson,1 M. Lian,1 B. Jones,1 P. Hughes.1

    1Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia; 2Nephrology Surgery, Royal Melbourne Hospital, Melbourne, Australia

    PURPOSEWe have previously studied the barriers preventing patients from being made active on the transplant waiting list (TWL) and implemented practice changes to improve the…
  • 2017 American Transplant Congress

    Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?

    K. Zorbas,1 S. Karhadkar,1 S. Rao,2 K. Lau,1 I. Lee,2 A. Gillespie,2 S. Constantinescu,2 A. Karachristos,1 A. Di Carlo.1

    1Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; 2Nephrology, Temple University, Philadelphia, PA

    Obesity is a significant barrier for kidney transplantation (KT) with higher rates of denial for listing and longer listing to transplantation interval. We examined the…
  • 2017 American Transplant Congress

    An Analysis of Tacrolimus XL Dosing in Obese Kidney Transplant Recipients.

    N. Jasiak, J. Thielke, K. Progar, J. Chen, C. Adams, E. Benedetti, P. West-Thielke.

    Univ of Ill, Chicago

    Background:Tacrolimus extended-release (XL) is utilized in many immunosuppressive regimens post-kidney transplantation. Current dosing recommendation for the XL formulation in renal transplant (txp) is 0.15 mg/kg/day…
  • 2017 American Transplant Congress

    Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.

    D. Hesselink,1 L. Andrews,2 B. de Winter,2 J. Tang,3 N. Shuker,2 R. Bouamar,2 R. van Schaik,4 B. Koch,2 T. Van Gelder.1

    1Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands; 3Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China; 4Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands

    Bodyweight-based dosing of tacrolimus (Tac) is considered standard care, even though the available evidence is thin. An increasing proportion of transplant recipients is overweight, prompting…
  • 2017 American Transplant Congress

    Access to Simultaneous Pancreas and Kidney Transplant (SPK) Should Not Be Restricted to BMI > 28.

    M. Laftavi, A. Gruessner, V. Whittaker, Z. Acun, O. Pankowycz, R. Gruessner.

    SUNY Upstate Medical University, Syracuse, NY

    Background: Currently, UNOS guidelines require that uremic, insulin-dependent type 1 diabetic patients have a body mass index (BMI) < 28m/kg2 in order to be eligible…
  • 2017 American Transplant Congress

    Impact of Body Mass Index and Waist Circumference in Kidney Transplant Recipients.

    J.-E. Serre, M. Huet, I. Scwarc, V. Pernin, M. Le Quintrec, G. Mourad.

    Department of Nephrology, University Hospital of Montpellier, Montpellier, France, Metropolitan

    Introduction: The impact of obesity defined by a body mass index [BMI] > 30 kg/m[sup2] on kidney allograft outcomes remains controversial. The use of BMI…
  • 2017 American Transplant Congress

    Impact of Bariatric Surgery on Risk of Organ Rejection Among Solid Organ Transplant Recipients.

    M. Soghikian, D. Gregory, J. Wilcox, A. Shetty, D. Ladner, L. VanWagner.

    Medicine, Northwestern University, Chicago, IL; Surgery, Northwestern University, Chicago, IL

    Background: Obesity is a common condition that contributes to organ failure. Bariatric surgery is an effective surgical therapy for obesity and has been performed both…
  • 2017 American Transplant Congress

    Muscle Mass Is Predictive of Mortality in Obese Renal Transplant Patients.

    J. Souweine,1,3 M. Le Quintrec,1 I. Szwarc,1 V. Pernin,1 G. Mourad,1 J. Cristol,2,3 J. Serre.1

    1Nephrology, University Hospital of Montpellier, Montpellier, France; 2Biochemistry, University Hospital of Montpellier, Montpellier, France; 3PhyMedExp, UMR CNRS 9214, INSERM U1046, University Hospital of Montpellier, Montpellier, France

    Introduction: The impact of obesity (body mass index [BMI] > 30 kg/m[sup2]) on kidney allograft outcomes is controversial. Recent studies found that obesity does not…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences